Current and historical daily PE Ratio for EBOSF (
Ebos Group Ltd
) from 2014 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ebos Group stock (EBOSF) PE ratio as of Apr 25 2024 is 23.73.
More Details
Ebos Group Ltd (EBOSF) PE Ratio (TTM) Chart
Ebos Group Ltd (EBOSF) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1213
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Ebos Group PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-25 | 31.2 | 2024-02-21 | 31.2 |
| 2024-04-24 | 31.2 | 2024-02-20 | 31.2 |
| 2024-04-23 | 31.2 | 2024-02-16 | 31.2 |
| 2024-04-22 | 31.2 | 2024-02-15 | 31.2 |
| 2024-04-19 | 31.2 | 2024-02-14 | 31.2 |
| 2024-04-18 | 31.2 | 2024-02-13 | 31.2 |
| 2024-04-17 | 31.2 | 2024-02-12 | 31.2 |
| 2024-04-16 | 31.2 | 2024-02-09 | 31.2 |
| 2024-04-15 | 31.2 | 2024-02-08 | 31.2 |
| 2024-04-12 | 31.2 | 2024-02-07 | 31.2 |
| 2024-04-11 | 31.2 | 2024-02-06 | 31.2 |
| 2024-04-10 | 31.2 | 2024-02-05 | 31.2 |
| 2024-04-09 | 31.2 | 2024-02-02 | 31.2 |
| 2024-04-08 | 31.2 | 2024-02-01 | 31.2 |
| 2024-04-05 | 31.2 | 2024-01-31 | 31.2 |
| 2024-04-04 | 31.2 | 2024-01-30 | 31.2 |
| 2024-04-03 | 31.2 | 2024-01-29 | 31.2 |
| 2024-04-02 | 31.2 | 2024-01-26 | 31.2 |
| 2024-04-01 | 31.2 | 2024-01-25 | 31.2 |
| 2024-03-28 | 31.2 | 2024-01-24 | 31.2 |
| 2024-03-27 | 31.2 | 2024-01-23 | 31.2 |
| 2024-03-26 | 31.2 | 2024-01-22 | 31.2 |
| 2024-03-25 | 31.2 | 2024-01-19 | 31.2 |
| 2024-03-22 | 31.2 | 2024-01-18 | 31.2 |
| 2024-03-21 | 31.2 | 2024-01-17 | 31.2 |
| 2024-03-20 | 31.2 | 2024-01-16 | 31.2 |
| 2024-03-19 | 31.2 | 2024-01-12 | 31.2 |
| 2024-03-18 | 31.2 | 2024-01-11 | 31.2 |
| 2024-03-15 | 31.2 | 2024-01-10 | 31.2 |
| 2024-03-14 | 31.2 | 2024-01-09 | 31.2 |
| 2024-03-13 | 31.2 | 2024-01-08 | 31.2 |
| 2024-03-12 | 31.2 | 2024-01-05 | 31.2 |
| 2024-03-11 | 31.2 | 2024-01-04 | 31.2 |
| 2024-03-08 | 31.2 | 2024-01-03 | 31.2 |
| 2024-03-07 | 31.2 | 2024-01-02 | 31.2 |
| 2024-03-06 | 31.2 | 2023-12-29 | 31.2 |
| 2024-03-05 | 31.2 | 2023-12-28 | 31.2 |
| 2024-03-04 | 31.2 | 2023-12-27 | 31.3 |
| 2024-03-01 | 31.2 | 2023-12-26 | 31.3 |
| 2024-02-29 | 31.2 | 2023-12-22 | 31.3 |
| 2024-02-28 | 31.2 | 2023-12-21 | 31.3 |
| 2024-02-27 | 31.2 | 2023-12-20 | 31.3 |
| 2024-02-26 | 31.2 | 2023-12-19 | 31.3 |
| 2024-02-23 | 31.2 | 2023-12-18 | 31.3 |
| 2024-02-22 | 31.2 | 2023-12-15 | 31.3 |
Ebos Group Ltd (EBOSF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Ebos Group Ltd
ISIN : NZEBOE0001S6
Share Class Description:
EBOSF: Ordinary SharesCompare
Compare
Traded in other countries / regions
EBO.New ZealandEBO.AustraliaEJG.GermanyEBOSF.USA IPO Date
2014-08-13Description
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers